Drug Profile
Hepatitis C vaccine - Virionics
Alternative Names: Hepatitis C virus-like particle vaccine - Virionics; HepCVaxLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Virionics
- Class Hepatitis C vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C in USA
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C(Prevention) in USA